MS4A6E
geneOn this page
Summary
MS4A6E (membrane spanning 4-domains A6E, HGNC:14285) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 6E (Q96DS6). May be involved in signal transduction as a component of a multimeric receptor complex.
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. The gene encoding this protein is localized to 11q12.3, among a cluster of family members.
Source: NCBI Gene 245802 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 28 total
- MANE Select transcript:
NM_139249
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14285 |
| Approved symbol | MS4A6E |
| Name | membrane spanning 4-domains A6E |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000166926 |
| Ensembl biotype | protein_coding |
| OMIM | 608402 |
| Entrez | 245802 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 2 nonsense_mediated_decay
ENST00000300182, ENST00000530509, ENST00000532756, ENST00000684409, ENST00000969922
RefSeq mRNA: 1 — MANE Select: NM_139249
NM_139249
CCDS: CCDS7984
Canonical transcript exons
ENST00000684409 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001107846 | 60339866 | 60339964 |
| ENSE00001107847 | 60337741 | 60337947 |
| ENSE00003918550 | 60327255 | 60327408 |
| ENSE00003919667 | 60334882 | 60335042 |
| ENSE00003921061 | 60340776 | 60341341 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 96.67.
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.67 | gold quality |
| right testis | UBERON:0004534 | 96.35 | gold quality |
| testis | UBERON:0000473 | 93.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.27 | gold quality |
| sperm | CL:0000019 | 92.66 | gold quality |
| adult organism | UBERON:0007023 | 87.37 | gold quality |
| monocyte | CL:0000576 | 82.25 | gold quality |
| leukocyte | CL:0000738 | 79.35 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.76 | gold quality |
| spleen | UBERON:0002106 | 71.33 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.97 | gold quality |
| rectum | UBERON:0001052 | 66.38 | gold quality |
| vermiform appendix | UBERON:0001154 | 65.80 | gold quality |
| tibialis anterior | UBERON:0001385 | 65.15 | silver quality |
| subcutaneous adipose tissue | UBERON:0002190 | 64.43 | gold quality |
| granulocyte | CL:0000094 | 63.58 | gold quality |
| right coronary artery | UBERON:0001625 | 63.29 | gold quality |
| caecum | UBERON:0001153 | 60.25 | gold quality |
| lymph node | UBERON:0000029 | 59.49 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 58.73 | gold quality |
| gall bladder | UBERON:0002110 | 58.49 | gold quality |
| upper lobe of lung | UBERON:0008948 | 58.02 | gold quality |
| adipose tissue | UBERON:0001013 | 57.23 | gold quality |
| omental fat pad | UBERON:0010414 | 57.13 | gold quality |
| peritoneum | UBERON:0002358 | 57.08 | gold quality |
| left uterine tube | UBERON:0001303 | 56.74 | gold quality |
| left adrenal gland | UBERON:0001234 | 56.45 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 56.36 | gold quality |
| right lung | UBERON:0002167 | 56.26 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 56.06 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 4.54 |
| E-ANND-3 | yes | 4.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting MS4A6E, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-338-3P | 98.14 | 67.38 | 1137 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
| HSA-MIR-4689 | 96.97 | 65.79 | 1209 |
| HSA-MIR-5586-5P | 96.29 | 68.02 | 685 |
| HSA-MIR-6858-5P | 96.05 | 64.59 | 1020 |
Literature-anchored findings (GeneRIF, showing 1)
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. (PMID:21460841)
Cross-species orthologs
31 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ms4a17a.6 | ENSDARG00000007018 |
| danio_rerio | ms4a17a.4 | ENSDARG00000014024 |
| danio_rerio | si:dkey-77f5.10 | ENSDARG00000020548 |
| danio_rerio | zgc:113425 | ENSDARG00000026616 |
| danio_rerio | ms4a17c.2 | ENSDARG00000028659 |
| danio_rerio | ms4a17a.7 | ENSDARG00000043796 |
| danio_rerio | ms4a17a.1 | ENSDARG00000043798 |
| danio_rerio | ms4a17a.8 | ENSDARG00000043802 |
| danio_rerio | ms4a17a.12 | ENSDARG00000053563 |
| danio_rerio | ms4a17a.16 | ENSDARG00000054898 |
| danio_rerio | si:dkey-7j14.6 | ENSDARG00000090552 |
| danio_rerio | ms4a17a.3 | ENSDARG00000091970 |
| danio_rerio | ms4a17a.5 | ENSDARG00000092204 |
| danio_rerio | si:dkey-174k12.3 | ENSDARG00000092593 |
| danio_rerio | si:dkey-238j22.1 | ENSDARG00000093512 |
| danio_rerio | si:ch73-56d11.5 | ENSDARG00000093546 |
| danio_rerio | ms4a17c.1 | ENSDARG00000094643 |
| danio_rerio | ms4a17a.11 | ENSDARG00000094809 |
| danio_rerio | ms4a17a.9 | ENSDARG00000094854 |
| danio_rerio | ms4a17a.10 | ENSDARG00000095695 |
| danio_rerio | si:ch73-56d11.3 | ENSDARG00000097527 |
| danio_rerio | tmem176l.3a | ENSDARG00000098387 |
| danio_rerio | ms4a17a.2 | ENSDARG00000105674 |
| danio_rerio | ms4a17a.17 | ENSDARG00000116378 |
| mus_musculus | Ms4a6b | ENSMUSG00000024677 |
| mus_musculus | Ms4a6d | ENSMUSG00000024679 |
| mus_musculus | Ms4a6c | ENSMUSG00000079419 |
| rattus_norvegicus | Ms4a6a | ENSRNOG00000020991 |
| rattus_norvegicus | Ms4a6bl1 | ENSRNOG00000030689 |
| rattus_norvegicus | Ms4a6b | ENSRNOG00000047349 |
| rattus_norvegicus | Ms4a6bl1 | ENSRNOG00000050395 |
Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Membrane-spanning 4-domains subfamily A member 6E — Q96DS6 (reviewed: Q96DS6)
All UniProt accessions (3): Q96DS6, H0YD45, H0YEW2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in signal transduction as a component of a multimeric receptor complex.
Subcellular location. Membrane.
Tissue specificity. Expressed by malignant and fetal tissue at very low levels.
Similarity. Belongs to the MS4A family.
RefSeq proteins (1): NP_640342* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
Pfam: PF04103
UniProt features (9 total): topological domain 3, sequence variant 3, transmembrane region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96DS6-F1 | 63.77 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOCC_TRANS_GOLGI_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, BOSCO_TH1_CYTOTOXIC_MODULE, MIR587, MIR586, MIR338_3P, MIR5004_5P, MIR1224_5P, DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS, GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT, chr11q12, GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN, GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN, GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN, GOCC_GOLGI_APPARATUS
GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): trans-Golgi network (GO:0005802), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| binding | 1 |
| Golgi apparatus subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
314 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MS4A6E | MS4A4E | Q96PG1 | 977 |
| MS4A6E | MS4A4A | Q96JQ5 | 976 |
| MS4A6E | MS4A10 | Q96PG2 | 929 |
| MS4A6E | MS4A12 | Q9NXJ0 | 927 |
| MS4A6E | MS4A8 | Q9BY19 | 921 |
| MS4A6E | ABCA7 | Q8IZY2 | 720 |
| MS4A6E | CD2AP | Q9Y5K6 | 718 |
| MS4A6E | PICALM | Q13492 | 696 |
| MS4A6E | EPHA1 | P21709 | 669 |
| MS4A6E | SORL1 | Q92673 | 627 |
| MS4A6E | BIN1 | O00499 | 624 |
| MS4A6E | CLU | P10909 | 610 |
| MS4A6E | ZCWPW1 | Q9H0M4 | 606 |
| MS4A6E | CD33 | P20138 | 594 |
| MS4A6E | MS4A5 | Q9H3V2 | 584 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJB2 | MS4A6E | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A6E | UBE2J1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A6E | ATP11C | psi-mi:“MI:0914”(association) | 0.350 |
| MS4A6E | POF1B | psi-mi:“MI:0914”(association) | 0.350 |
| GJB2 | MS4A6E | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBE2J1 | MS4A6E | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): MS4A6E (Two-hybrid), UBE2J1 (Two-hybrid), ATP11C (Affinity Capture-MS), CCDC167 (Affinity Capture-MS), EVPL (Affinity Capture-MS), CALML5 (Affinity Capture-MS), POF1B (Affinity Capture-MS)
ESM2 similar proteins: A4IIU3, A6NGA9, A6NML5, D3YWQ9, O75204, P0DP42, P11836, P13386, P19437, P20490, P56749, Q01362, Q0IIL2, Q2KHT4, Q32KQ5, Q3SZ72, Q3T110, Q3UNB8, Q3YBM2, Q497B3, Q4G068, Q504G0, Q5EB63, Q5FWC3, Q5HYL7, Q5R8D6, Q5R9K1, Q5RCD5, Q5REZ6, Q6AXT9, Q6GV27, Q7YQI4, Q8BGP5, Q8C6V3, Q8K177, Q8R1W2, Q8VHW1, Q8VI88, Q8WXS4, Q920C4
Diamond homologs: Q96DS6, Q99N07, Q99N08, Q99N09, Q9H2W1, A6QPF4, P13386, P20490, Q01362, Q3UPL6, Q8N5U1, Q96HJ5, Q96JA4, Q96JQ5, Q99N05, Q9GZW8, Q9H3V2, Q9NXJ0, Q3C1V0, Q920C4, Q9BY19, Q96PG2, Q99N10
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1482 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:60335023:C:T | donor_gain | 1.0000 |
| 11:60335029:TCA:T | donor_gain | 1.0000 |
| 11:60335035:T:G | donor_gain | 1.0000 |
| 11:60335038:TTGGG:T | donor_loss | 1.0000 |
| 11:60335040:GGG:G | donor_gain | 1.0000 |
| 11:60335041:GGG:G | donor_gain | 1.0000 |
| 11:60335042:GGTAA:G | donor_loss | 1.0000 |
| 11:60337649:A:G | donor_gain | 1.0000 |
| 11:60337944:GGCT:G | donor_gain | 1.0000 |
| 11:60337945:GCTG:G | donor_gain | 1.0000 |
| 11:60337948:G:GG | donor_gain | 1.0000 |
| 11:60340774:A:AG | acceptor_gain | 1.0000 |
| 11:60340775:G:GG | acceptor_gain | 1.0000 |
| 11:60335041:GG:G | donor_gain | 0.9900 |
| 11:60335042:GG:G | donor_gain | 0.9900 |
| 11:60335044:T:A | donor_loss | 0.9900 |
| 11:60337654:GGAA:G | donor_gain | 0.9900 |
| 11:60337655:G:T | donor_gain | 0.9900 |
| 11:60337735:TTTCA:T | acceptor_loss | 0.9900 |
| 11:60337736:TTCA:T | acceptor_loss | 0.9900 |
| 11:60337738:CAGGT:C | acceptor_loss | 0.9900 |
| 11:60337739:A:G | acceptor_loss | 0.9900 |
| 11:60337740:GGTGC:G | acceptor_gain | 0.9900 |
| 11:60337845:GT:G | donor_gain | 0.9900 |
| 11:60337943:TGGCT:T | donor_gain | 0.9900 |
| 11:60337944:GGCTG:G | donor_gain | 0.9900 |
| 11:60337945:GCT:G | donor_gain | 0.9900 |
| 11:60337946:CT:C | donor_gain | 0.9900 |
| 11:60337946:CTGTA:C | donor_loss | 0.9900 |
| 11:60337947:TGTA:T | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000128694 (11:60345138 G>A,T), RS1000343296 (11:60339142 A>T), RS1000375136 (11:60325957 T>C), RS1000540893 (11:60329150 C>A,T), RS1000572082 (11:60328947 T>C), RS1000794216 (11:60338227 T>A), RS1000886783 (11:60331911 A>T), RS1001043330 (11:60344820 TCC>T), RS1001064818 (11:60343931 C>T), RS1001180140 (11:60345040 T>C), RS1001210413 (11:60344455 A>G), RS1001306358 (11:60344726 G>A), RS1001497019 (11:60325447 G>C,T), RS1001539996 (11:60343576 T>A,C), RS1001555925 (11:60332915 T>C)
Disease associations
OMIM: gene MIM:608402 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002817_25 | Alzheimer’s disease in APOE e4- carriers | 2.000000e-09 |
| GCST003262_560 | Post bronchodilator FEV1 | 3.000000e-06 |
| GCST010058_1 | Hematological and biochemical traits | 1.000000e-06 |
| GCST90002393_230 | Monocyte count | 8.000000e-24 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004314 | forced expiratory volume |
| EFO:0007629 | hemoglobin A1 measurement |
| EFO:0005091 | monocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Arbutin | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Nanotubes, Carbon | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Alzheimer disease